{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:07:07Z","timestamp":1788883627256,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"National Cancer Institute Division of Cancer Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.omtn.2026.103020","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:28:15Z","timestamp":1785576495000},"page":"103020","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tuning lipid nanoparticle pKa to exploit the vitronectin corona for tumor-selective mRNA delivery to the lung"],"prefix":"10.1016","volume":"37","author":[{"given":"Yoon Tae","family":"Goo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-036X","authenticated-orcid":false,"given":"Olena R.","family":"Taratula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6227-9110","authenticated-orcid":false,"given":"Oleh","family":"Taratula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103020_bib1","article-title":"Development of mRNA lipid nanoparticles: targeting and therapeutic aspects","volume":"25","author":"Liu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2026.103020_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102375","article-title":"Discovery of peptides for ligand-mediated delivery of mRNA lipid nanoparticles to cystic fibrosis lung epithelia","volume":"35","author":"Soto","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103020_bib3","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1016\/j.ymthe.2025.03.018","article-title":"CD47 peptide-cloaked lipid nanoparticles promote cell-specific mRNA delivery","volume":"33","author":"Papp","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2026.103020_bib4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1021\/acschembio.0c00003","article-title":"Engineering caveolae-targeted lipid nanoparticles to deliver mRNA to the lungs","volume":"15","author":"Li","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.omtn.2026.103020_bib5","doi-asserted-by":"crossref","first-page":"L217","DOI":"10.1152\/ajplung.2000.278.1.L217","article-title":"Vascular expression of the \u03b1v\u03b23-integrin in lung and other organs","volume":"278","author":"Singh","year":"2000","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.omtn.2026.103020_bib6","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.3892\/mmr.2014.2860","article-title":"Integrin \u03b1v promotes proliferation by activating ERK 1\/2 in the human lung cancer cell line A549","volume":"11","author":"Fu","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omtn.2026.103020_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7150\/thno.4218","article-title":"Role of urokinase receptor in tumor progression and development","volume":"3","author":"Noh","year":"2013","journal-title":"Theranostics"},{"key":"10.1016\/j.omtn.2026.103020_bib8","article-title":"Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia","volume":"18","author":"Korzun","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.omtn.2026.103020_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3892\/or.2022.8318","article-title":"Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer","volume":"47","author":"Daitoku","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omtn.2026.103020_bib10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1080\/14728222.2020.1799350","article-title":"Activin A: an emerging target for improving cancer treatment?","volume":"24","author":"Ries","year":"2020","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126001915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T15:11:51Z","timestamp":1788880311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126001915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2162253126001915"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103020","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuning lipid nanoparticle pKa to exploit the vitronectin corona for tumor-selective mRNA delivery to the lung","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103020"}}